The conference proceedings preview is composed of speaker biographies and abstracts, along with selected PowerPoint presentations. Registered attendees receive a CD with the full version of the proceedings on May 27, 2010. In addition, registered attendees will receive an updated online version two weeks after the conference.

To view the preview, please click on the following link:

http://www.gtcbio.com/Ocular_Preview/main.htm

Click here to register! Register two, the third goes free.

CONFERENCE HIGHLIGHTS

Keynote Presentation – Megan McLaughlin, Discovery Medicine, Ophthiris DPU, GlaxoSmithKline

Pazopanib Eye Drops for Neovascular AMD

Keynote Presentation – Stephen Tsang, Edward S. Harkness Eye Institute, Columbia University

Transplantation of Reprogrammed Embryonic Stem Cells Improves Visual Function in a Mouse Model for Retinitis Pigmentosa

Conference Sessions:

I:    Age-Related Macular Degeneration
II:   Recent Drug Developments & Mechanisms in Ocular Diseases
III:   Ocular Diseases
IV:  Future of Ocular Diseases Therapeutics
V:   Novel Drug Delivery Methods

For a full agenda visit: http://gtcbio.com/userAgenda.aspx?id=148

Register 2, the 3rd person goes free! Click here to register.

Distinguished Presenters:

+ Megan M. McLaughlin – Keynote Speaker, Ophthiris Discovery Performance Unit, GlaxoSmithKline  + Stephen Tsang, M.D., Ph.D. – Keynote Speaker, Edward S. Harkness Eye Institute, Columbia University  + Barbara Marie Wirostko, M.D. – Featured Speaker, Senior Medical Director, Team Lead Ophthalmology, Pfizer  + Charles S. Tressler, M.D. – Featured Speaker, Senior Director, Global Medical, Pfizer  + Richard L. Beckman, M.D., Senior Vice President, Development, Lux Biosciences  + Robert M. Burk, Ph.D., Senior Research Investigator, Allergan  + Bo Chen, Department of Genetics, Howard Hughes Medical Institute, Harvard Medical School  + Daniel C. Chung, DO, MA, Instructor of Ophthalmology, University of Pennsylvania School of Medicine  + Robert J. Collier, Ph.D., Associate Director, Retina Drug Discovery, Alcon Research  + Valeriu Damian, Manager, GlaxoSmithKline  + Darlene A. Dartt, Scepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School  + Philip D. Gregory, Ph.D., Chief Scientific Officer, Sangamo BioSciences  + Avner Ingerman, M.D., M.Sc, Senior Vice President, General Manager, ORA Clinical R&D  + Konrad Kauper, Director, Tissue Engineering, Neurotech  + Ivan B. Lobov, Ph.D., Staff Scientist, Ophthalmology Therapeutics, Regeneron  + Karen Meerovitch, Ph.D., Senior Director, Mimetogen Pharmaceuticals  + Takahiro Ogawa, Ph.D., Senior Vice President, Research and Development, Senju USA  + George W. Ousler III, Director of Dry Eye, ORA Clinical Research and Development  + Michael A. Patane, Ph.D., Chief Scientific Officer, EyeGate Pharmaceuticals  + Przemyslaw Mike Sapieha, Ph.D., Assistant Professor, Ophthalmology, University of Montreal  + Abraham Scaria, Ph.D., Senior Scientific Director, Genzyme  + David Sherris, Ph.D., President and Chief Executive Officer, Paloma Pharmaceuticals  + Craig Struble, Ph.D., Associate Technical Director, Drug Metabolism, Covance  + Jennifer Sun, M.D., MPH, Beetham Eye Institute, Joslin Diabetes Center  + Corinne G. Wong, Ph.D., Principal, Chief Scientific Officer, SCLERA  + Wai T. Wong, M.D., Ph.D., Chief, Unit on Neuron-Glia Interactions in Retinal Disease, National Eye Institute, NIH  + David F. Woodward, Ph.D., Senior Director, Allergan